Akebia Therapeutics, Inc.

Q4 2019 13F Holders

Symbol
AKBA
CUSIP
00972D105
Type
Equity
Class
COM
Num filers
155
Total reported value, excl. options
$532M
Manager Report Date Value ($000) Shares